ArticleJournal of public health research2025
Breaking barriers: Enhancing hospital support for sickle cell disease management.
Article in Journal of public health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sickle cell disease (SCD) management requires comprehensive care coordination and specialised resources, particularly in endemic regions. We describe the implementation and outcomes of a unique model, the Integrated Centre for Sickle Cell Disease (CID), in French Guiana, a region with high SCD prevalence. Design and methods: We established a comprehensive SCD care centre incorporating dedicated clinical space, specialised staff, and integrated emergency services. The model included 24/7 specialist availability, priority admission protocols, and a day hospital facility for managing acute complications. Results: The CID currently serves 740 patients (280 children, 406 adults, including 23 elderly patients aged 60-72 years). In 2022, the centre documented 4673 patient visits, comprising 2209 consultations and 417-day hospitalisations. Of these day hospitalisations, 229 were for vaso-occlusive crises, 147 for erythropheresis, 13 for therapeutic bleeding, and 28 for plasmaphaeresis. Most notably, following CID's establishment, emergency room deaths were eliminated, compared to 2-3 annual deaths previously reported due to acute splenic sequestration. The centre maintained this achievement over eight consecutive years. Conclusions: The CID model demonstrates successful implementation of comprehensive SCD care in a resource-limited setting. The complete elimination of emergency room deaths over 8 years, along with improved patient retention and follow-up, suggests that this model could serve as a template for other regions with high SCD prevalence. The success of this approach highlights the importance of integrated, specialised care in managing SCD effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.